NCT06197022 - Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) | Biotech Hunter

Enrollment

106

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Coronary Artery Disease

Interventions

DEVICE

Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter

Combination of scoring-balloon angioplasty (SBA) plus sirolimus-eluting balloon angioplasty (SEBA) for diffuse (lesion length ≥20 mm), small vessel (diameter 1.5 mm -2.75 mm) coronary disease.

Trial Locations (1)

7000

RECRUITING

Medica Core Heart Hopsital, Rousse